PrognomiQ Appoints Joel Kaufman as Chief Financial Officer PrognomiQ Announces the appointment of Joel Kaufman as Chief Financial Officer, serving on the company's Executive Team.

PrognomiQ Announces $34 Million Series D Financing to Advance Development of Early Detection Test for Lung Cancer with Multi-omics Platform PrognomiQ Announces $34 Million Series D Financing to Advance Development of Early Detection Test for Lung Cancer with Multi-omics Platform